Corona Remedies Limited logo

Corona Remedies Limited (CORONA)

Market Closed
10 Aug, 22:00
MSE MSE
2,082. 35
+21.4
+1.0384%
103.87B Market Cap
- P/E Ratio
- Div Yield
2,249 Volume
- Eps
2,060.95
Previous Close
Add Transaction
Day Range
2,038.85 2,090.05
Year Range
1,062 2,261.4
Want to track CORONA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CORONA closed today higher at ₹2,082.35, an increase of 1.0384% from yesterday's close, completing a monthly increase of 4.2243% or ₹84.4. Over the past 12 months, CORONA stock gained 50.2742%.
CORONA is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).

CORONA Chart

Corona Remedies Limited (CORONA) FAQ

What is the stock price today?

The current price is ₹2,082.35.

On which exchange is it traded?

Corona Remedies Limited is listed on MSE.

What is its stock symbol?

The ticker symbol is CORONA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 103.87B.

Has Corona Remedies Limited ever had a stock split?

No, there has never been a stock split.

Corona Remedies Limited Profile

- Industry
- Sector
Mr. Niravkumar Kirtikumar Mehta CEO
MSE Exchange
- ISIN
India Country
4,508 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Corona Remedies Limited is an established Indian pharmaceutical formulation company dedicated to the development, manufacturing, and marketing of branded generic medicines. With a robust focus on multiple therapeutic areas, the company has made significant inroads into women’s healthcare, cardiology, pain management, urology, and various other chronic therapies. It boasts a diversified portfolio comprising dozens of brands, predominantly positioned in the mid-market segment. This strategic positioning allows Corona Remedies Limited to effectively target extensive prescription demand while maintaining healthy operating margins.

The company’s commercial operations span across India, bolstered by an extensive network of medical representatives and a wide distribution framework designed to reach doctors, hospitals, and pharmacies, especially in non-metro and underpenetrated markets. Financially, Corona Remedies Limited has shown a consistent upward trajectory in terms of revenue and profit growth, complemented by strong return ratios such as return on capital employed and return on equity. This performance illustrates the efficient utilization of capital within the business. Additionally, within the evolving healthcare ecosystem, the company plays a vital role in increasing the accessibility of essential therapies for chronic and lifestyle diseases in India's rapidly expanding domestic pharmaceutical market.

Products and Services

  • Branded Generic Medicines: Corona Remedies Limited specializes in the development and marketing of branded generic medicines that offer similar efficacy to their branded counterparts but at a more accessible price point. This approach allows them to cater to a broad demographic while ensuring patient affordability.
  • Women’s Healthcare Solutions: The company has a dedicated focus on women’s health, providing products designed to address various healthcare needs unique to women, including gynecological and reproductive health products. This area demonstrates their commitment to improving health outcomes for women across India.
  • Cardiology Products: With a strong presence in cardiology, Corona Remedies offers a range of medications targeting heart health. These products are aimed at managing conditions such as hypertension, heart failure, and other cardiovascular diseases, contributing to the overall well-being of patients at risk.
  • Pain Management Therapies: The company provides various pain management solutions designed to alleviate chronic pain and improve quality of life for patients. These products range from analgesics to combination therapies, emphasizing efficacy and safety.
  • Urology Products: Corona Remedies has developed a series of urological products that address conditions affecting the urinary tract and male reproductive systems. Their commitment to this area helps ensure better health management for individuals facing urological challenges.
  • Chronic Therapy Products: Beyond the specific therapeutic areas mentioned, the company also engages in the development of products for other chronic conditions, providing essential treatments that span various long-term health issues, thereby enhancing patient care in the broader chronic disease management landscape.

Contact Information

Address: Corona House
Phone: 91 79 4023 3000